COH29
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for COH29, covering 2025-07-04 to 2025-07-04. Get the full timeline:
Most recent: Clinical Trial Update: RNR Inhibitor COH29 in Treating Patients With Solid Tumors That Are Refractory to Standard Therapy or For Which No Standard Therapy Exists [Phase 1]